Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1131464

Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview


Švob Štrac, Dubravka; Konjevod, Marcela; Sagud, Marina; Nikolac Perković, Matea; Nedić Erjavec, Gordana; Vuić, Barbara; Šimić, Goran; Vukić, Vana; Mimica, Ninoslav; Pivac, Nela
Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview // Pharmacogenomics and Personalized Medicine, 14 (2021), 631-653 doi:10.2147/pgpm.s284615 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1131464 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview

Autori
Švob Štrac, Dubravka ; Konjevod, Marcela ; Sagud, Marina ; Nikolac Perković, Matea ; Nedić Erjavec, Gordana ; Vuić, Barbara ; Šimić, Goran ; Vukić, Vana ; Mimica, Ninoslav ; Pivac, Nela

Izvornik
Pharmacogenomics and Personalized Medicine (1178-7066) 14 (2021); 631-653

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Alzheimer disease ; epigenetics ; gut microbiota ; precision medicine ; therapy

Sažetak
Alzheimer's disease (AD) is a progressive, complex, and multifactorial neurodegenerative disorder, still without effective and stable therapeutic strategies. Currently, available medications for AD are based on symptomatic therapy, which include acetylcholinesterase (AChE) inhibitors and N-methyl-D-aspartate (NMDA) receptor antagonist. Additionally, medications such as antipsychotic drugs, antidepressants, sedative, and hypnotic agents, and mood stabilizers are used for the management of behavioral and psychological symptoms of dementia (BPSD). Clinical research has been extensively investigated treatments focusing on the hallmark pathology of AD, including the amyloid deposition, tau hyperphosphorylation, neuroinflammation, and vascular changes ; however, so far without success, as all new potential drugs failed to show significant clinical benefit. The underlying heterogeneous etiology and diverse symptoms of AD suggest that a precision medicine strategy is required, which would take into account the complex genetic, epigenetic, and environmental landscape of each AD patient. The article provides a comprehensive overview of the literature on AD, the current and potential therapy of both cognitive symptoms as well as BPSD, with a special focus on gut microbiota and epigenetic modifications as new emerging drug targets. Their specific patterns could represent the basis for novel individually tailored approaches aimed to optimize precision medicine strategies for AD prevention and treatment. However, the successful application of precision medicine to AD demands a further extensive research of underlying pathological processes, as well as clinical and biological complexity of this multifactorial neurodegenerative disorder.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
HRZZ-IP-2019-04-6100 - Terapijski potencijal neurosteroida i neurotrofina u demenciji (TePoNeDe) (Švob Štrac, Dubravka, HRZZ - 2019-04) ( CroRIS)

Ustanove:
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb,
Klinika za psihijatriju Vrapče,
Klinički bolnički centar Zagreb

Poveznice na cjeloviti tekst rada:

doi www.dovepress.com

Citiraj ovu publikaciju:

Švob Štrac, Dubravka; Konjevod, Marcela; Sagud, Marina; Nikolac Perković, Matea; Nedić Erjavec, Gordana; Vuić, Barbara; Šimić, Goran; Vukić, Vana; Mimica, Ninoslav; Pivac, Nela
Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview // Pharmacogenomics and Personalized Medicine, 14 (2021), 631-653 doi:10.2147/pgpm.s284615 (međunarodna recenzija, članak, znanstveni)
Švob Štrac, D., Konjevod, M., Sagud, M., Nikolac Perković, M., Nedić Erjavec, G., Vuić, B., Šimić, G., Vukić, V., Mimica, N. & Pivac, N. (2021) Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview. Pharmacogenomics and Personalized Medicine, 14, 631-653 doi:10.2147/pgpm.s284615.
@article{article, author = {\v{S}vob \v{S}trac, Dubravka and Konjevod, Marcela and Sagud, Marina and Nikolac Perkovi\'{c}, Matea and Nedi\'{c} Erjavec, Gordana and Vui\'{c}, Barbara and \v{S}imi\'{c}, Goran and Vuki\'{c}, Vana and Mimica, Ninoslav and Pivac, Nela}, year = {2021}, pages = {631-653}, DOI = {10.2147/pgpm.s284615}, keywords = {Alzheimer disease, epigenetics, gut microbiota, precision medicine, therapy}, journal = {Pharmacogenomics and Personalized Medicine}, doi = {10.2147/pgpm.s284615}, volume = {14}, issn = {1178-7066}, title = {Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview}, keyword = {Alzheimer disease, epigenetics, gut microbiota, precision medicine, therapy} }
@article{article, author = {\v{S}vob \v{S}trac, Dubravka and Konjevod, Marcela and Sagud, Marina and Nikolac Perkovi\'{c}, Matea and Nedi\'{c} Erjavec, Gordana and Vui\'{c}, Barbara and \v{S}imi\'{c}, Goran and Vuki\'{c}, Vana and Mimica, Ninoslav and Pivac, Nela}, year = {2021}, pages = {631-653}, DOI = {10.2147/pgpm.s284615}, keywords = {Alzheimer disease, epigenetics, gut microbiota, precision medicine, therapy}, journal = {Pharmacogenomics and Personalized Medicine}, doi = {10.2147/pgpm.s284615}, volume = {14}, issn = {1178-7066}, title = {Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview}, keyword = {Alzheimer disease, epigenetics, gut microbiota, precision medicine, therapy} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font